EML4-ALK G1202R
|
NSCLC
|
EML4-ALK G1202R
|
NSCLC
|
ALK inhibitor + STAT3 inhibitor Sensitive: C3 – Early Trials
|
ALK inhibitor + STAT3 inhibitor Sensitive: C3 – Early Trials
|
EML4-ALK G1202R
|
NSCLC
|
EML4-ALK G1202R
|
NSCLC
|
ceritinib Resistant: D – Preclinical
|
ceritinib Resistant: D – Preclinical
|